ONO-2020

DRUG3 trials

Sponsors

Ono Pharmaceutical Co. Ltd, Ono Pharmaceutical Co., Ltd.

Conditions

Agitation Associated With Alzheimer's Disease DementiaAlzheimer DiseaseHealthy Volunteers

Phase 1

A Phase 1 Study of ONO-2020 in Healthy Participants

CompletedNCT05507515

Ono Pharmaceutical Co. LtdHealthy Volunteers

Start: 2022-07-29End: 2023-12-24Updated: 2024-04-09

Phase 2

A Study of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia

RecruitingNCT06803823

Ono Pharmaceutical Co., Ltd.Agitation Associated With Alzheimer's Disease Dementia

Start: 2025-05-01End: 2027-03-31Target: 90Updated: 2026-05-12

A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease

Active, not recruitingNCT06881836

Ono Pharmaceutical Co., Ltd.Alzheimer Disease

Start: 2025-04-24End: 2026-09-01Updated: 2026-08-31